These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 28612287

  • 1. Methylation markers differentiate thyroid cancer from benign nodules.
    Stephen JK, Chen KM, Merritt J, Chitale D, Divine G, Worsham MJ.
    J Endocrinol Invest; 2018 Feb; 41(2):163-170. PubMed ID: 28612287
    [Abstract] [Full Text] [Related]

  • 2. Gene expression of thyroid-specific transcription factors may help diagnose thyroid lesions but are not determinants of tumor progression.
    Batista FA, Ward LS, Marcello MA, Martins MB, Peres KC, Torricelli C, Bufalo NE, Soares FA, da Silva MJ, Assumpção LV.
    J Endocrinol Invest; 2016 Apr; 39(4):423-9. PubMed ID: 26370671
    [Abstract] [Full Text] [Related]

  • 3. DNA Methylation-Based Method to Differentiate Malignant from Benign Thyroid Lesions.
    Barros-Filho MC, Dos Reis MB, Beltrami CM, de Mello JBH, Marchi FA, Kuasne H, Drigo SA, de Andrade VP, Saieg MA, Pinto CAL, Kowalski LP, Rogatto SR.
    Thyroid; 2019 Sep; 29(9):1244-1254. PubMed ID: 31328658
    [Abstract] [Full Text] [Related]

  • 4. DNA Methylation Haplotype Block Markers Efficiently Discriminate Follicular Thyroid Carcinoma from Follicular Adenoma.
    Zhang H, Zhang Z, Liu X, Duan H, Xiang T, He Q, Su Z, Wu H, Liang Z.
    J Clin Endocrinol Metab; 2021 Mar 25; 106(4):1011-1021. PubMed ID: 33394038
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Alterations of regulatory factors and DNA methylation pattern in thyroid cancer.
    Iancu IV, Botezatu A, Plesa A, Huica I, Fudulu A, Albulescu A, Bostan M, Mihaila M, Grancea C, Manda DA, Dobrescu R, Vladoiu SV, Anton G, Badiu CV.
    Cancer Biomark; 2020 Mar 25; 28(2):255-268. PubMed ID: 32390600
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. IS MEASUREMENT OF CIRCULATING TUMOR DNA OF DIAGNOSTIC USE IN PATIENTS WITH THYROID NODULES?
    Lupo M, Guttler R, Geck Z, Tonozzi TR, Kammesheidt A, Braunstein GD.
    Endocr Pract; 2018 May 25; 24(5):453-459. PubMed ID: 29498908
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Genetic markers differentiating follicular thyroid carcinoma from benign lesions.
    Freitas BC, Cerutti JM.
    Mol Cell Endocrinol; 2010 May 28; 321(1):77-85. PubMed ID: 19932149
    [Abstract] [Full Text] [Related]

  • 14. Molecular Testing for Oncogenic Gene Alterations in Pediatric Thyroid Lesions.
    Mostoufi-Moab S, Labourier E, Sullivan L, LiVolsi V, Li Y, Xiao R, Beaudenon-Huibregtse S, Kazahaya K, Adzick NS, Baloch Z, Bauer AJ.
    Thyroid; 2018 Jan 28; 28(1):60-67. PubMed ID: 29108474
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Methylation status of TSHr in well-differentiated thyroid cancer by using cytologic material.
    Kartal K, Onder S, Kosemehmetoglu K, Kilickap S, Tezel YG, Kaynaroglu V.
    BMC Cancer; 2015 Oct 30; 15():824. PubMed ID: 26519197
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Carbonic anhydrase 4 and crystallin α-B immunoreactivity may distinguish benign from malignant thyroid nodules in patients with indeterminate thyroid cytology.
    Davidov T, Nagar M, Kierson M, Chekmareva M, Chen C, Lu SE, Lin Y, Chernyavsky V, Potdevin L, Arumugam D, Barnard N, Trooskin S.
    J Surg Res; 2014 Aug 30; 190(2):565-74. PubMed ID: 24880201
    [Abstract] [Full Text] [Related]

  • 19. Comprehensive DNA Methylation Profiling Identifies Novel Diagnostic Biomarkers for Thyroid Cancer.
    Park JL, Jeon S, Seo EH, Bae DH, Jeong YM, Kim Y, Bae JS, Kim SK, Jung CK, Kim YS.
    Thyroid; 2020 Feb 30; 30(2):192-203. PubMed ID: 31797753
    [Abstract] [Full Text] [Related]

  • 20. Molecular testing for indeterminate thyroid nodules: Performance of the Afirma gene expression classifier and ThyroSeq panel.
    Jug RC, Datto MB, Jiang XS.
    Cancer Cytopathol; 2018 Jul 30; 126(7):471-480. PubMed ID: 29637728
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.